Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionProvidence Wealth Advisors, LLC
Latest Disclosed Ownership5,793 shares
Latest Disclosed Value $ 2,044,871
Providence Wealth Advisors, LLC reports 0.85% increase in ownership of AMGN / Amgen Inc.

On May 5, 2026 - Providence Wealth Advisors, LLC filed a 13F-HR form disclosing ownership of 5,793 shares of Amgen Inc. (CH:AMGN) valued at $2,044,871 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 5,744 shares of Amgen Inc.. This represents a change in shares of 0.85% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COM 031162100 5,793 49 0.85 2,045 11.63 1.2856
2026-02-06 2025-12-31 13F AMGEN COM 031162100 5,744 35 0.61 1,831 9.84 1.1438
2025-11-05 2025-09-30 13F AMGEN COM 031162100 5,709 -45 -0.78 1,668 1.46 1.0520
2025-08-12 2025-06-30 13F AMGEN COM 031162100 5,754 120 2.13 1,643 -4.70 1.1282
2025-05-07 2025-03-31 13F AMGEN COM 031162100 5,634 63 1.13 1,725 19.47 1.3064
2025-02-12 2024-12-31 13F AMGEN COM 031162100 5,571 50 0.91 1,443 -17.26 1.0923
2024-11-14 2024-09-30 13F AMGEN COM 031162100 5,521 110 2.03 1,745 2.53 1.2903
2024-08-09 2024-06-30 13F AMGEN COM 031162100 5,411 120 2.27 1,701 16.11 1.3564
2024-05-13 2024-03-31 13F AMGEN COM 031162100 5,291 3,165 148.87 1,466 -44.74 1.2513
2024-02-14 2023-12-31 13F AMGEN COM 031162100 2,126 -2,781 -56.67 2,651 103.61 2.3942
2023-11-13 2023-09-30 13F AMGEN COM 031162100 4,907 80 1.66 1,302 19.45 1.4536
2023-08-08 2023-06-30 13F AMGEN COM 031162100 4,827 -315 -6.13 1,090 -13.35 1.2065
2023-05-11 2023-03-31 13F AMGEN COM 031162100 5,142 40 0.78 1,259 -7.57 0.9294
2023-02-13 2022-12-31 13F AMGEN COM 031162100 5,102 125 2.51 1,362 -7.16 1.0114
2022-11-14 2022-09-30 13F AMGEN COM 031162100 4,977 -192 -3.71 1,466 15.34 1.0949
2022-08-10 2022-06-30 13F AMGEN COM 031162100 5,169 419 8.82 1,271 10.04 0.9170
2022-05-10 2022-03-31 13F AMGEN COM 031162100 4,750 96 2.06 1,155 8.15 0.7425
2022-01-12 2021-12-31 13F AMGEN COM 031162100 4,654 10 0.22 1,068 7.77 0.6711
2021-11-15 2021-09-30 13F AMGEN COM 031162100 4,644 15 0.32 991 -13.37 0.6896
2021-08-12 2021-06-30 13F AMGEN COM 031162100 4,629 -4 -0.09 1,144 -0.78 0.7810
2021-05-17 2021-03-31 13F AMGEN COM 031162100 4,633 225 5.10 1,153 15.18 0.8469
2021-02-16 2020-12-31 13F AMGEN COM 031162100 4,408 226 5.40 1,001 -5.83 0.8310
2020-11-10 2020-09-30 13F AMGEN COM 031162100 4,182 758 22.14 1,063 31.56 1.0498
2020-08-07 2020-06-30 13F AMGEN COM 031162100 3,424 140 4.26 808 22.61 0.8241
2020-05-05 2020-03-31 13F AMGEN COM 031162100 3,284 75 2.34 659 -14.42 0.7953
2020-01-29 2019-12-31 13F AMGEN COM 031162100 3,209 -400 -11.08 770 10.32 0.7084
2019-11-12 2019-09-30 13F AMGEN COM 031162100 3,609 35 0.98 698 5.92 0.6230
2019-07-22 2019-06-30 13F AMGEN COM 031162100 3,574 35 0.99 659 -2.66 0.6131
2019-04-18 2019-03-31 13F AMGEN COM 031162100 3,539 147 4.33 677 4.64 0.6367
2019-02-02 2018-12-31 13F AMGEN COM 031162100 3,392 0 0.00 647 -7.97 0.7179
2018-11-01 2018-09-30 13F AMGEN COM 031162100 3,392 -4 -0.12 703 12.12 0.6414
2018-08-13 2018-06-30 13F AMGEN COM 031162100 3,396 55 1.65 627 12.97 0.6105
2018-08-13 2018-03-31 13F AMGEN COM 031162100 3,341 3,341 555 0.8216
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.